Xcout Intel
Biodesix, Inc. competitors & alternatives
The 12 closest competitors and alternatives to Biodesix, Inc. among medical - diagnostics & research companies — ranked by similarity to what Biodesix, Inc. actually does, not by market-cap band.
Subscribe to see Biodesix, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Biodesix, Inc.
Biodesix, Inc. is a public diagnostic solutions company founded in 2006 and headquartered in Louisville, Colorado. The company specializes in diagnostic testing and development services focused on discovering blood-based tests for cancer management.
Biodesix, Inc. at a glance
Biodesix, Inc. is a medical - diagnostics & research company headquartered in Louisville, United States. It is publicly listed (BDSX) with a market capitalisation of $274.5M. Xcout tracks 18 named people at Biodesix, Inc., including Scott Hutton (President, Chief Executive Officer & Director).
Biodesix, Inc. leadership
- Scott HuttonPresident, Chief Executive Officer & Director
- Robin Harper CowieChief Financial Officer, Secretary & Treasurer
- Kieran O'KaneChief Commercial Officer
- Bobbi CoffinChief Growth Officer
- Gary Anthony PestanoChief Scientific Officer
- James R. JettCo-Chief Medical Officer
12 more named people on record for Biodesix, Inc., with roles, board committees and tenure — see the full roster →
Biodesix, Inc. funding rounds before its IPO
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | $4.9M | — |
Financing after the IPO — public offerings and SEC Form D private placements — is not listed as a funding round.
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Biodesix, Inc. competitors
Ranked by semantic similarity — how close each company is to Biodesix, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology
Resolution Bioscience is a precision medicine company specializing in cancer diagnostics, DNA sequencing, and liquid biopsy, located in Bellevue, Washington.
Biotech
Gene Solutions LLC provides AI-powered genetic testing and multi-dimensional genomics services focused on oncology and reproductive health. The company offers blood-based early cancer detection tests, tumor profiling, and minimal residual disease monitoring for patients and healthcare providers.
Diagnostics
Exosome Diagnostics, Inc. is a molecular diagnostics company located in Massachusetts, United States. The company specializes in developing biofluid-based liquid biopsy tests, such as the ExoDx Prostate test, for use in personalized medicine and oncology.
Biotechnology
MDNA Life Sciences, Inc. develops non-invasive, blood-based diagnostic tests utilizing patented mitochondrial DNA technology to detect diseases such as cancer at early stages. The company serves patients and healthcare providers by offering accurate screening solutions designed to improve disease detection and reduce the need for unnecessary invasive surgeries.
Biotechnology & Healthcare
Protean BioDiagnostics Inc. is a diagnostic company based in the United States that provides advanced cancer profiling systems and laboratory testing services.
Biotechnology
Predicine Holdings Ltd provides next-generation liquid biopsy platforms and molecular profiling services for cancer research and precision medicine. The company utilizes proprietary blood- and urine-based assays to analyze circulating tumor DNA and RNA, serving biopharmaceutical partners and clinical researchers in oncology drug development and clinical trials.
Biotech
Precede Biosciences is a biotechnology company developing blood-based liquid-biopsy technologies for molecular profiling of cancer. Its tests are intended to support oncology research, precision treatment decisions, and pharmaceutical drug-development programs.
Biotech
Belay Diagnostics is a medical and diagnostic laboratory based in Chicago, Illinois, that specializes in precision medicine and cerebrospinal fluid liquid biopsies for central nervous system cancers.
Biotechnology
Nexosome Oncology Holdings, Inc. develops blood tests for early-stage cancer detection using patented extracellular vesicle proteomics and AI/ML biomarker discovery. The company serves patients and healthcare partners by providing highly accurate diagnostic tools.
Biotech
Syantra Diagnostics, based in Calgary, Canada, is developing a blood-based diagnostic test for breast cancer. This revolutionary test aims to be rapid, economical, and accurate, regardless of various factors, to improve breast cancer detection.
Life Sciences
PinkDx, Inc., also known as The Gyne Cancer Company, is headquartered in San Francisco, California. The company specializes in advanced gynecologic cancer diagnostics and developing innovative patient testing solutions.
Biotech
Exact Sciences Corporation is an American molecular diagnostics company based in Madison, Wisconsin, specializing in the detection of early-stage cancers. The company provides products for the detection and prevention of colorectal cancer, including Cologuard, the first stool DNA test for colorectal cancer, along with additional screening and precision oncological tests for other types of cancer.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Biodesix, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Biodesix, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →